{
    "2020-05-04": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Cytokinetics Trading at Half High Target of $30",
                "features": {
                    "keywords": [
                        "Cytokinetics",
                        "trading",
                        "half high target"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis AG (NVS): Were Hedge Funds Right About This Stock?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "hedge funds",
                        "right about stock"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Top Analyst Reports for Apple, Berkshire Hathaway & Pfizer",
                "features": {
                    "keywords": [
                        "analyst reports",
                        "Apple",
                        "Berkshire Hathaway",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "financial services",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Should You Buy Global Blood Therapeutics Before This Week's Earnings?",
                "features": {
                    "keywords": [
                        "Global Blood Therapeutics",
                        "buy before earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}